😷 Effectiveness of COVID-19 vaccines in haemodialysis | RMHP - Dove Medical Press 👉 https://t.co/Kcdpyf5IYp 💊 #Medical #GroupZirigoza
RT @GCessak: Wyniki badań🇸🇦: u pacjentów z chorobami nerek leczonych hemodializą, szczepienie schematem podstawowym Pfizer/AstraZeneca indu…
Wyniki badań🇸🇦: u pacjentów z chorobami nerek leczonych hemodializą, szczepienie schematem podstawowym Pfizer/AstraZeneca indukowało odpowiedź humoralną utrzymującą się do min. 3 miesięcy po II dawce. Potwierdza to zasadność szczepień w tej grupie chorych.
RT @WMahallawi: Pleased to share with you our last work this year, thanks for our supporter @taibahu @DsrTaibahu and special thanks for…
RT @WMahallawi: Pleased to share with you our last work this year, thanks for our supporter @taibahu @DsrTaibahu and special thanks for…
RT @WMahallawi: Pleased to share with you our last work this year, thanks for our supporter @taibahu @DsrTaibahu and special thanks for…
RT @WMahallawi: Pleased to share with you our last work this year, thanks for our supporter @taibahu @DsrTaibahu and special thanks for…
Pleased to share with you our last work this year, thanks for our supporter @taibahu @DsrTaibahu and special thanks for my team @nadiribrahim @WMouminah https://t.co/eqc0xcUHcK